Related Experiment Video
Updated: Aug 18, 2026
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Contrast-enhanced MRI lesions during treatment with interferonbeta-1b predict increase in T1 black hole volume in
K Morgen1, A L T Crawford, R D Stone
1National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA Katrin.Morgen@neuro.med.uni-giessen.de
Abstract:
T1 black holes (BH) have been found to represent focal areas of substantial central nervous system tissue damage in multiple sclerosis (MS) patients. We examined the development of T1 BH over a three-year period of treatment with interferon (IFN)beta-1b in a group of 20 patients with relapsing-remitting MS. The number of contrast-enhancing lesions (CEL) after one year of treatment predicted a change in the T1 BH volume in the following two years. In patients without CEL, the T1 BH volume remained stable, whereas it increased in patients with CEL. The occurrence of CEL in patients treated with IFNbeta may indicate a heightened risk of accumulating T1 BH.
